Death or bronchopulmonary dysplasia · respiratory failure in preterm infants
Inhaled NO showed no clear difference in death or bronchopulmonary dysplasia at 36 weeks ‐ Studies with entry… compared with control (high certainty).
1 finding from 1 review
Intraventricular haemorrhage, Papile grade 3/4 · respiratory failure in preterm infants
Inhaled NO showed no clear difference in intraventricular haemorrhage (grade 3 or 4) ‐ Studies with entry… compared with control (high certainty).
1 finding from 1 review
Neurodevelopmental disability · respiratory failure in preterm infants
Inhaled NO showed no clear difference in neurodevelopmental disability ‐ Studies with entry before 3 days… compared with control (moderate certainty).
1 finding from 1 review
Oxygen requirement at 36 weeks' postmenstrual age · very low birth weight preterm neonates
Early inhaled steroids (< 2 weeks) showed no clear difference in CLD at 36 weeks' PMA oxygen dependency at 36 weeks' PMA compared with placebo (among all randomised) (moderate certainty).
1 finding from 1 review
Death by, or CLD at, 36 weeks' PMA Death or oxygen dependency at 36 weeks' PMA · very low birth weight preterm neonates
Early inhaled steroids (< 2 weeks) probably leads to lower death by, or CLD at, 36 weeks' PMA Death or oxygen dependency at 36… compared with placebo (among all randomised) (moderate certainty).
1 finding from 1 review
Intervention not reported
Duration of supplemental oxygen (days) · Preterm neonates with respiratory distress
1 finding from 1 review
Inspired oxygen concentration % (study definition) · neonates up to 44 weeks' postmenstrual age
1 finding from 1 review
BPD at 28 days · neonates up to 44 weeks' postmenstrual age
Volume‐targeted showed no clear difference in BPD (supplemental oxygen at 28 days) compared with pressure‐limited ventilation: additional findings (low certainty).
1 finding from 1 review
Oxygen requirement at 36 weeks' postmenstrual age · neonates up to 44 weeks' postmenstrual age
Volume‐targeted may leads to lower BPD (supplemental oxygen at 36 weeks) compared with pressure‐limited ventilation: main findings (low certainty).
1 finding from 1 review
Episodes of oxygen desaturation · spontaneously breathing preterm infants with apnoea
1 finding from 1 review
Episodes of oxygen desaturation · spontaneously breathing preterm infants with apnoea
1 finding from 1 review
Episodes of oxygen desaturation · spontaneously breathing preterm infants with apnoea
1 finding from 1 review
Episodes of oxygen desaturation · spontaneously breathing preterm infants with apnoea
1 finding from 1 review
Episodes of oxygen desaturation · spontaneously breathing preterm infants with apnoea
1 finding from 1 review
Episodes of oxygen desaturation · spontaneously breathing preterm infants with apnoea
1 finding from 1 review
Episodes of oxygen desaturation · spontaneously breathing preterm infants with apnoea
1 finding from 1 review
Duration of oxygen therapy (hours) · preterm infants with chronic lung disease
1 finding from 1 review
Change in oxygenation index ‐ After 24 hours of treatment · pulmonary hypertension in neonates
1 finding from 1 review
Duration of oxygen therapy (hours) · symptomatic neonates born through meconium‐stained amniotic fluid
1 finding from 1 review
Duration of oxygen therapy (hours) · asymptomatic neonates born through meconium‐stained amniotic fluid
1 finding from 1 review